The California Department of Justice (DOJ) will release the optimized Controlled Substance Utilization Review and Evaluation System (CURES) on April 11, 2022. Please refer to the DOJ guidance document “ New Optimized Cures Being Released On 4/11/2022” for important information on new features of the optimized CURES, supported web browsers, and planned system downtime from Friday, April 8, 2022 at 5:00 PM, through Monday, April 11, 2022 at 8:00 AM.
After this deployment, the initial login to CURES, whether via the web application or the Information Exchange Web Service (IEWS), will require users to follow the steps outlined below and in the DOJ bulletin:
Step #1: Login to CURES with your username and Password.
Step #2: Review and agree to the CURES Terms and Conditions.
Step #3: Verify your DOJ Identity by completing five (5) personal identity questions
- First Name at Birth
- Last Name at Birth
- Mothers Maiden Name
- Place of Birth
- Date of Birth
Step #3 is to be completed by the user only one time. If the user does not complete this step the first time they login to the optimized CURES, they will be prompted to do this step every time they login until this is completed.
In addition, CURES optimization will provide expanded Delegate functionality, through which Delegates will be authorized to directly access data in CURES. Practitioners currently utilizing a Delegate must enter into a new Delegate Agreement in order for their Delegate to have continued access to CURES beginning April 11, 2022.
New Delegates may also be added via Delegate Agreement. For information about the Delegate access, please refer to the DOJ guidance document “ New Features and Requirements for Expanded Delegate Access.”
As part of the transition to optimized CURES, beginning on April 11, 2022, users will need to complete a few simple steps the first time they log into the system. For more information, please refer to the DOJ guidance document “ First Time Login to the New Optimized CURES.”
If you have any questions about optimized CURES, Delegate Access, or browser accessibility, contact the CURES Program at email@example.com or (916) 210-3187.